Surgical Resection of Thymoma Still Represents the First Choice of Treatment

Ried, M. and Guth, H. and Potzger, T. and Diez, C. and Neu, R. and Schalke, B. and Hofmann, H. -S. (2012) Surgical Resection of Thymoma Still Represents the First Choice of Treatment. THORACIC AND CARDIOVASCULAR SURGEON, 60 (2). pp. 145-149. ISSN 0171-6425, 1439-1902

Full text not available from this repository. (Request a copy)

Abstract

Objective The aim of this study was to analyze the clinicopathological factors, treatment strategies and survival rates after surgical resection of thymoma. Methods Between 12/1997 and 5/2010, 42 patients underwent surgical resection of the thymus. The presence of a thymoma was determined by histological examination in 23 patients, while patients with hyperplasia of the thymus (n = 19) were excluded from further analysis. Results Myasthenia gravis coexisted in 9/23 (39.1%) patients. Thymomas were classified according to the Masaoka staging system (I: n = 6 [26.1%], IIa: n = 7 [30.4%], IIb: n = 2 [8.7%], III: n = 1 [4.4%], IVa: n = 7 [30.4%]) and the WHO histological classification (A: n = 4 [17.4%], AB: n = 5 [21.7%], B1: n = 1 [4.4%], B2: n = 8 [34.8%], B3: n = 3 [13%], C: n = 2 [8.7%]). Recurrence of thymoma was documented in three (13%) patients. After a mean follow-up of 58.4 months, 21 (91.3%) patients are alive. The overall survival rate was 95% and 87.8%, at 2 and 5 years, respectively. The disease-free interval at 5 years was 85% for the 17 (73.9%) patients with complete resection. Conclusions Surgical resection of thymoma is the preferred treatment, because it is safe and effective with a low rate of recurrence and a good long-termsurvival. Advanced and invasive thymomas require a multimodal approach for better local tumor control and further improvement of prognosis.

Item Type: Article
Uncontrolled Keywords: THYMIC EPITHELIAL TUMORS; HYPERTHERMIC INTRATHORACIC CHEMOTHERAPY; MYASTHENIA-GRAVIS; PATHOLOGICAL PREDICTORS; CYTOREDUCTIVE SURGERY; PROGNOSTIC-FACTORS; CARCINOMA; SURVIVAL; MASAOKA; PERFUSION; thymoma; thymic carcinoma; thymus hyperplasia; myasthenia gravis
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Abteilung für Thoraxchirurgie
Medicine > Lehrstuhl für Neurologie
Depositing User: Dr. Gernot Deinzer
Date Deposited: 19 May 2020 04:57
Last Modified: 19 May 2020 04:57
URI: https://pred.uni-regensburg.de/id/eprint/19137

Actions (login required)

View Item View Item